Risk minimisation materials: Spravato (esketamine) 28 mg nasal spray - Healthcare Professional Guide

Guide describes risk of transient dissociative states and perception disorders (dissociation), disturbances in consciousness, increased blood pressure and drug abuse and advises how to minimise and manage them. Accompanied by a readiness-to-leave checklist after Spravato

Source:

electronic Medicines compendium